Lv4
770 积分 2022-06-20 加入
HIV immune evasin Nef enhances allogeneic CAR T cell potency
1个月前
已完结
Extended follow-up of in vivo BCMA CAR-T therapy in relapsed/refractory multiple myeloma
1个月前
已完结
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
1个月前
已完结
CD70-targeted allogeneic CAR T-cell therapy for clear cell renal cell carcinoma
1个月前
已完结
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
1个月前
已关闭
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已完结
mRNA-encoding CD19-targeting T cell engager for refractory immune thrombocytopenia
1个月前
已完结
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
2个月前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
2个月前
已完结